Across TCGA pan-cancer cohorts, MIR548I2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR548I2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR548I2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR548I2 is over-expressed in tumor, although a few such as UCEC and LUSC show the opposite, repressed pattern.

STAD, UCEC, and LUSC are the cancer types where MIR548I2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR548I2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.956	<.001	6	view →
UCEC	All	All	−0.345	.020	4	view →
LUSC	Male	All	−0.211	.016	2	view →
COAD	Female	III,IV	−0.414	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR548I2 RNA expression & survival · all MIR548I2 data types